Adamts-7 as a Biomarker for Cancers of Epithelial Origin
First Claim
Patent Images
1. A method for facilitating the diagnosis of a patient for a cancer of epithelial origin comprising:
- a. obtaining a biological sample from the patient; and
b. detecting the presence or absence of ADAMTS-7 in the biological sample,wherein the presence of ADAMTS-7 is indicative of the presence of cancer of epithelial origin.
1 Assignment
0 Petitions
Accused Products
Abstract
ADAMTS-7 expression and activity are up regulated in patients that have cancers of epithelial origin. Accordingly, the present invention is directed to methods diagnosis of cancers of epithelial origin (e.g. breast cancer, prostate cancer, bladder cancer, brain cancer and hepatic cancer). In particular, the presence of ADAMTS-7 in a biological sample is indicative of cancer of epithelial origin. Thus, measuring the level of ADAMTS-7 in biological samples (e.g. urine or blood) provides a quick, easy, and safe screen that can be used to diagnose cancer in a patient.
-
Citations
20 Claims
-
1. A method for facilitating the diagnosis of a patient for a cancer of epithelial origin comprising:
-
a. obtaining a biological sample from the patient; and b. detecting the presence or absence of ADAMTS-7 in the biological sample, wherein the presence of ADAMTS-7 is indicative of the presence of cancer of epithelial origin. - View Dependent Claims (2, 3, 7, 8, 12, 13, 14, 15)
-
-
4. A method for diagnosing cancer of epithelial origin in a patient comprising:
-
a. measuring ADAMTS-7 levels present in a test sample obtained from the patient; b. comparing the level of ADAMTS-7 in the test sample with the level of ADAMTS-7 present in a control sample; wherein a higher level of ADAMTS-7 in the test sample as compared to the level of ADAMTS-7 in the control sample is indicative of cancer of epithelial origin. - View Dependent Claims (5, 6, 9, 10, 11)
-
-
16. A kit for detecting ADAMTS-7 in a urine sample comprising a container for holding a urine sample, and at least one antibody that specifically binds ADAMTS-7.
- 18. The kit of claim 18, further comprising directions for use.
- 19. A method to direct treatment of a subject which comprises having a subject tested for the presence of ADAMTS-7 in a biological sample obtained from the subject, wherein a clinician reviews the results and if the biological sample is positive for the presence of ADAMTS-7 the clinician directs the subject to be treated for cancer of epithelial origin.
Specification